Max Meyrath

872 total citations
22 papers, 573 citations indexed

About

Max Meyrath is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Max Meyrath has authored 22 papers receiving a total of 573 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 12 papers in Immunology and 8 papers in Molecular Biology. Recurrent topics in Max Meyrath's work include Chemokine receptors and signaling (12 papers), Immunotherapy and Immune Responses (8 papers) and T-cell and B-cell Immunology (8 papers). Max Meyrath is often cited by papers focused on Chemokine receptors and signaling (12 papers), Immunotherapy and Immune Responses (8 papers) and T-cell and B-cell Immunology (8 papers). Max Meyrath collaborates with scholars based in Luxembourg, Belgium and Germany. Max Meyrath's co-authors include Andy Chevigné, Martyna Szpakowska, Markus Ollert, Martin Augsten, Elin Sjöberg, Arne Östman, Tomasz Uchański, Evi Kostenis, Julien Hanson and John Lövrot and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Journal of Virology.

In The Last Decade

Max Meyrath

22 papers receiving 571 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Max Meyrath Luxembourg 14 307 225 212 102 45 22 573
Julie Sanchez Australia 11 181 0.6× 199 0.9× 231 1.1× 70 0.7× 33 0.7× 19 498
Anders Björk Sweden 10 121 0.4× 297 1.3× 439 2.1× 80 0.8× 43 1.0× 11 860
Ursula Bodendorf Switzerland 11 125 0.4× 61 0.3× 336 1.6× 42 0.4× 46 1.0× 17 595
Carol S. Ryan United States 9 197 0.6× 309 1.4× 283 1.3× 22 0.2× 45 1.0× 10 647
Guoxiang Wu China 9 160 0.5× 147 0.7× 280 1.3× 107 1.0× 27 0.6× 12 494
John Q. Davies United Kingdom 8 72 0.2× 232 1.0× 492 2.3× 201 2.0× 42 0.9× 10 768
Helen Kylefjord Sweden 8 119 0.4× 77 0.3× 329 1.6× 20 0.2× 57 1.3× 13 555
Edmond M. Linossi Australia 11 251 0.8× 236 1.0× 231 1.1× 18 0.2× 48 1.1× 17 551
Natalii J. Paczkowski Australia 8 50 0.2× 292 1.3× 223 1.1× 76 0.7× 30 0.7× 8 531
Mani Ravichandran Canada 8 140 0.5× 116 0.5× 488 2.3× 31 0.3× 88 2.0× 8 670

Countries citing papers authored by Max Meyrath

Since Specialization
Citations

This map shows the geographic impact of Max Meyrath's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Max Meyrath with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Max Meyrath more than expected).

Fields of papers citing papers by Max Meyrath

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Max Meyrath. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Max Meyrath. The network helps show where Max Meyrath may publish in the future.

Co-authorship network of co-authors of Max Meyrath

This figure shows the co-authorship network connecting the top 25 collaborators of Max Meyrath. A scholar is included among the top collaborators of Max Meyrath based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Max Meyrath. Max Meyrath is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bosma, Reggie, Max Meyrath, Susanne M. A. van der Pol, et al.. (2025). Inhibition of constitutive activity of the atypical chemokine receptor 3 by the small-molecule inverse agonist VUF16840. Molecular Pharmacology. 107(12). 100085–100085. 1 indexed citations
2.
Meyrath, Max, Martyna Szpakowska, Olivia Domingues, et al.. (2022). Nanoluciferase-based cell fusion assay for rapid and high-throughput assessment of SARS-CoV-2-neutralizing antibodies in patient samples. Methods in enzymology on CD-ROM/Methods in enzymology. 675. 351–381. 4 indexed citations
3.
Meyrath, Max, Tomasz Uchański, Bernard Rogister, et al.. (2022). Nanoluciferase-based methods to monitor activation, modulation and trafficking of atypical chemokine receptors. Methods in cell biology. 169. 279–294. 12 indexed citations
4.
Meyrath, Max, et al.. (2022). Nanoluciferase-based complementation assay for systematic profiling of GPCR–GRK interactions. Methods in cell biology. 169. 309–321. 6 indexed citations
5.
Meyrath, Max, Tomasz Uchański, Toon Laeremans, et al.. (2022). The Extended N-Terminal Domain Confers Atypical Chemokine Receptor Properties to CXCR3-B. Frontiers in Immunology. 13. 868579–868579. 13 indexed citations
6.
Meyrath, Max, et al.. (2021). Atypical opioid receptors: unconventional biology and therapeutic opportunities. Pharmacology & Therapeutics. 233. 108014–108014. 24 indexed citations
7.
Meyrath, Max, Alain Vanderplasschen, Markus Ollert, et al.. (2021). Proadrenomedullin N-Terminal 20 Peptides (PAMPs) Are Agonists of the Chemokine Scavenger Receptor ACKR3/CXCR7. ACS Pharmacology & Translational Science. 4(2). 813–823. 26 indexed citations
8.
Collins, Paul J., Mieke Metzemaekers, Max Meyrath, et al.. (2020). CXCL14 Preferentially Synergizes With Homeostatic Chemokine Receptor Systems. Frontiers in Immunology. 11. 561404–561404. 22 indexed citations
9.
Sjöberg, Elin, Max Meyrath, Andy Chevigné, et al.. (2020). The diverse and complex roles of atypical chemokine receptors in cancer: From molecular biology to clinical relevance and therapy. Advances in cancer research. 145. 99–138. 27 indexed citations
10.
Meyrath, Max, Martyna Szpakowska, Laurent Massotte, et al.. (2020). The atypical chemokine receptor ACKR3/CXCR7 is a broad-spectrum scavenger for opioid peptides. Nature Communications. 11(1). 3033–3033. 82 indexed citations
11.
Meyrath, Max, et al.. (2020). Systematic reassessment of chemokine-receptor pairings confirms CCL20 but not CXCL13 and extends the spectrum of ACKR4 agonists to CCL22. Journal of Leukocyte Biology. 109(2). 373–376. 21 indexed citations
12.
Sjöberg, Elin, Max Meyrath, Laura Milde, et al.. (2019). A Novel ACKR2-Dependent Role of Fibroblast-Derived CXCL14 in Epithelial-to-Mesenchymal Transition and Metastasis of Breast Cancer. Clinical Cancer Research. 25(12). 3702–3717. 87 indexed citations
13.
Wouters, Elise, Michael J. Robertson, Max Meyrath, et al.. (2019). Assessment of Biased Agonism among Distinct Synthetic Cannabinoid Receptor Agonist Scaffolds. ACS Pharmacology & Translational Science. 3(2). 285–295. 49 indexed citations
14.
Neirinckx, Virginie, Ann‐Christin Hau, Anne Schuster, et al.. (2019). The soluble form of pan-RTK inhibitor and tumor suppressor LRIG1 mediates downregulation of AXL through direct protein–protein interaction in glioblastoma. Neuro-Oncology Advances. 1(1). vdz024–vdz024. 3 indexed citations
15.
Vasudevan, Lakshmi, Elise Wouters, Annelies Cannaert, et al.. (2019). Bioassays to study biased signalling of novel synthetic opioids. Annales de Toxicologie Analytique. 31(2). S66–S66. 1 indexed citations
16.
17.
Schenk, Christian, Max Meyrath, Uwe Warnken, et al.. (2018). Characterization of a Threonine-Rich Cluster in Hepatitis C Virus Nonstructural Protein 5A and Its Contribution to Hyperphosphorylation. Journal of Virology. 92(24). 6 indexed citations
18.
Szpakowska, Martyna, Max Meyrath, David Rhainds, et al.. (2017). Different contributions of chemokine N‐terminal features attest to a different ligand binding mode and a bias towards activation of ACKR3/CXCR7 compared with CXCR4 and CXCR3. British Journal of Pharmacology. 175(9). 1419–1438. 49 indexed citations
19.
Harak, Christian, Max Meyrath, Inés Romero‐Brey, et al.. (2016). Tuning a cellular lipid kinase activity adapts hepatitis C virus to replication in cell culture. Nature Microbiology. 2(3). 16247–16247. 45 indexed citations
20.
Summers, Robert L., Max Meyrath, Cecília P. Sanchez, et al.. (2014). Multiple Drugs Compete for Transport via the Plasmodium falciparum Chloroquine Resistance Transporter at Distinct but Interdependent Sites. Journal of Biological Chemistry. 289(52). 36336–36351. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Julie Sanchez Breakdown of academic impact, for papers by Anders Björk Breakdown of academic impact, for papers by Ursula Bodendorf Breakdown of academic impact, for papers by Carol S. Ryan Breakdown of academic impact, for papers by Guoxiang Wu Breakdown of academic impact, for papers by John Q. Davies Breakdown of academic impact, for papers by Helen Kylefjord Breakdown of academic impact, for papers by Edmond M. Linossi Breakdown of academic impact, for papers by Natalii J. Paczkowski Breakdown of academic impact, for papers by Mani Ravichandran
Rankless by CCL
2026